Status:
COMPLETED
MRI in McArdle Disease (GSDV)
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Glycogen Storage Disease Type V
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to describe the degree of muscle wasting in patients with McArdle disease judged by MRI, quantitative magnetic resonance (DIXON) and T1 weighted images, and muscle strength, c...
Eligibility Criteria
Inclusion
- GSDV or healthy controls
Exclusion
- MRI contradictions
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT03844022
Start Date
March 1 2018
End Date
February 1 2021
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen Neuromuscular Center, Rigshospitalet
Copenhagen, Denmark